CSIR-CCMB uncovers critical TB protein secretion targets (SecA1, Tat) revealing new drug targets to combat drug-resistant tuberculosis. Scientists at CSIR-CCMB have discovered critical weaknesses in Mycobacterium tuberculosis, potentially paving the way for new treatments against drug-resistant TB. India has the world’s largest number of Tuberculosis (TB) cases and more than three lakh is estimated to have died of TB in 2023, according to scientists.